Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3883 Target Snapshot

Dipeptidyl peptidase 4 · SINGLE PROTEIN · Mus musculus

86Compounds
51Assays
6Approved Drugs
68.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P28843. Use UniProt P28843 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P28843 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Dipeptidyl peptidase 4 as ChEMBL target CHEMBL3883, mapped to UniProt P28843. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Dipeptidyl peptidase 4
SINGLE PROTEIN · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL3883
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P28843
Dipeptidyl peptidase 4
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Dipeptidyl peptidase 4 is the right protein anchor across sources, using UniProt P28843 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDipeptidyl peptidase 4
UniProt AccessionP28843
Component TypeProtein
Sequence Length760 aa

Dipeptidyl peptidase 4

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Dipeptidyl peptidase 4, mapped to UniProt P28843. Sequence length is 760 aa.

Mapped IDP28843
Review nameDipeptidyl peptidase 4
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

6
Approved
Assay Mix

Activity Type Distribution

IC5068.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL237500 9.92 IC50 0.12 Approved
CHEMBL5859631 9.32 IC50 0.474 Preclinical
CHEMBL5968543 9.3 IC50 0.498 Preclinical
CHEMBL5993878 9.25 IC50 0.564 Preclinical
CHEMBL5411114 9.1 IC50 0.8 Preclinical
CHEMBL4463027 8.96 IC50 1.1 Preclinical
CHEMBL4593371 8.85 IC50 1.4 Preclinical
CHEMBL385517 8.72 IC50 1.9 Approved
CHEMBL4452661 8.7 IC50 2.0 Preclinical
CHEMBL5914544 8.69 IC50 2.03 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
1
5.5
1
6.0
11
6.5
13
7.0
11
7.5
8
8.0
9
8.5
4
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

OMARIGLIPTIN
CHEMBL2105762
Approved 2015
ALOGLIPTIN
CHEMBL376359
Approved 2013
LINAGLIPTIN
CHEMBL237500
Approved 2011
SAXAGLIPTIN ANHYDROUS
CHEMBL385517
Approved 2009
VILDAGLIPTIN
CHEMBL142703
Approved 2007
SITAGLIPTIN
CHEMBL1422
Approved 2006
Assay Landscape

Assay Landscape

51
Total Assays
58
Tested Compounds
2
Assay Types
Binding — 27 assays, 58 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 16 32 7.7
cell-free format 5 24 7.6
organism-based format 4 2 7.6
cell-based format 2 0
Functional — 24 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 23 0
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine